Ablation of stomach lining to treat obesity

• US 20040215180A1
• Filed: 04/25/2003
• Published: 10/28/2004
• Est. Priority Date: 04/25/2003
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Starkebaum, Warren L., Prentice, Thomas R.
• Application Number:
  US10/424,010
• Publication Number:
  US 20040215180A1
• Time in Patent Office: Days
• US Class Current: 606/32
• CPC Class Codes: A61B 18/1492 having a flexible, catheter-like structure, e.g. for heart ablation A61B18/1477 takes precedence
• CPC Class Codes: A61B 2018/00011 with fluids
• CPC Class Codes: A61B 2018/00065 porous
• CPC Class Codes: A61B 2018/00291 using suction
• CPC Class Codes: A61B 2018/00494 Stomach, intestines or bowel
• CPC Class Codes: A61B 2018/1467 using more than two electrodes on a single probe
• CPC Class Codes: B64F 1/305 Bridges extending between terminal building and aircraft, e.g. telescopic, vertically adjustable
• CPC Class Codes: G08B 21/182 Level alarms, e.g. alarms responsive to variables exceeding a threshold

Abstract

The invention provides methods and devices for ablation of stomach tissue to treat obesity. For example, the invention may involve ablation of mucosal tissue to inhibit ghrelin production, recognized as a root cause of increased appetite. The invention alternatively may involve ablation of sub-mucosal tissue to alter myoelectric activity and thereby induce gastroparesis. As a further alternative, gastric muscle tissue, vagal nerves within the stomach or the pyloric region may be ablated to alter stomach function and thereby induce gastroparesis.

Claims

1. A method for treating obesity, the method comprising ablating tissue within a stomach of a patient to inhibit ghrelin production by the tissue.

2. The method of claim 1, wherein ablating tissue includes ablating at least a portion of a mucosal lining of the stomach.

3. The method of claim 1, wherein ablating tissue includes ablating cells that produce ghrelin.

4. The method of claim 1, wherein ablating tissue includes:

introducing an ablation catheter to the stomach via an esophagus of the patient;

moving a distal end of the ablation catheter to a position proximal a mucosal lining of the stomach; and

activating an ablation probe carried by the ablation catheter to ablate at least a portion of the mucosal lining.

5. The method of claim 4, wherein the ablation probe includes an array of electrodes suspended at a distal end of the ablation catheter, the method further comprising moving the electrodes into contact with the mucosal lining, wherein activating the ablation probe includes delivering electrical current to the mucosal lining via the electrodes.

6. The method of claim 4, wherein the ablation probe includes a conductive coil extending from the distal end of the ablation catheter, the method further comprising moving the conductive coil into contact with the mucosal lining, wherein activating the ablation probe includes delivering electrical current to the mucosal lining via the conductive coil.

7. The method of claim 4, wherein the ablation probe includes a fluid delivery port at the distal end of the ablation catheter, and an electrode disposed adjacent the fluid delivery port, the method further comprising delivering fluid to the mucosal lining via the fluid delivery port, wherein activating the ablation probe includes delivering electrical current to the mucosal lining via the electrode and the fluid.

8. The method of claim 4, wherein the ablation probe includes an optical waveguide extending from the distal end of the ablation catheter, the method further comprising moving the optical waveguide into proximity with the mucosal lining, wherein activating the ablation probe includes delivering laser energy to the mucosal lining via the optical waveguide.

9. The method of claim 4, wherein the ablation probe includes a cryogenic probe, the method further comprising pacing the cryogenic probe in contact with the mucosal lining, wherein activating the ablation probe includes delivering cryogenic fluid to the cryogenic probe.

10. The method of claim 4, wherein the ablation catheter defines a cavity, one or more vacuum ports within the cavity, and the ablation probe is movable into the cavity, the method further comprising applying vacuum pressure to the vacuum ports to capture a portion of the mucosal lining within the cavity, and moving the ablation probe into the captured mucosal lining.

11. The method of claim 10, wherein the cavity defines a curvature to better conform to a curvature of the stomach.

12. The method of claim 10, wherein activating the ablation probe includes delivering electrical current to the captured mucosal lining via the ablation probe.

13. The method of claim 10, wherein activating the ablation probe includes delivering laser energy to the captured mucosal lining via the ablation probe.

14. The method of claim 10, wherein the ablation probe defines a conductive needle with a fluid delivery port, the method further comprising delivering fluid to the mucosal lining via the fluid delivery port, wherein activating the ablation probe includes delivering electrical current to the mucosal lining via the electrode and the fluid.

15. The method of claim 1, wherein the ablation catheter includes an inflatable balloon mounted adjacent a distal end of the ablation catheter, an electrode disposed within the balloon, and a fluid delivery port to deliver fluid to inflate the balloon, the balloon being sufficiently porous to permit flow of the fluid outside of the balloon, the method further comprising inflating the balloon, and placing the balloon in contact with the mucosal lining, wherein activating the ablation probe includes delivering electrical current to the mucosal lining via the electrode and the fluid within and outside the balloon.

16. The method of claim 15, wherein the balloon is sized, upon inflation, to contact a circumferential surface of the mucosal lining on multiple sides of the balloon.

17. The method of claim 15, wherein the balloon is sized, upon inflation, to contact a circumferential surface of a pylorus region of the stomach on multiple sides of the balloon.

18. An ablation system comprising:

a catheter sized for introduction into a stomach of a patient;

an ablation probe disposed at a distal end of the catheter; and

an ablation source to control delivery of ablation energy via the ablation probe in an amount sufficient to ablate tissue within the stomach of the patient and inhibit ghrelin production by the tissue.

19. The system of claim 18, wherein the catheter has a length sufficient to extend into the stomach of the patient via an esophagus of the patient.

20. The system of claim 18, wherein the ablation probe includes an array of electrodes suspended at the distal end of the ablation catheter, the ablation source delivering electrical current to the electrodes.

21. The system of claim 18, wherein the ablation probe includes a conductive coil extending from the distal end of the ablation catheter, the ablation source delivering electrical current to tissue via the electrodes.

22. The system of claim 18, wherein the ablation probe includes a fluid delivery port at the distal end of the ablation catheter, and an electrode disposed adjacent the fluid delivery port, the system further comprising a fluid source to deliver fluid via the fluid delivery port, wherein the ablation source delivers electrical current to the tissue via the electrode and the fluid.

23. The system of claim 18, wherein the ablation probe includes an optical waveguide extending from the distal end of the ablation catheter, wherein the ablation source delivers laser energy to the tissue via the optical waveguide.

24. The system of claim 18, wherein the ablation probe includes a cryogenic probe, wherein the ablation source delivers cryogenic fluid to the cryogenic probe.

25. The system of claim 18, wherein the ablation catheter defines a cavity, one or more vacuum ports within the cavity, and the ablation probe is movable into the cavity, the system further comprising a vacuum source to apply vacuum pressure to the vacuum ports to capture a portion of the tissue within the cavity, wherein the ablation probe ablates at least a portion of the captured mucosal lining.

26. The system of claim 25, wherein the cavity defines a curvature to conform to a curvature of the stomach.

27. The system of claim 25, wherein the ablation probe defines a conductive needle with a fluid delivery port, the system further comprising a fluid source to deliver fluid to the captured tissue via the fluid delivery port, wherein the ablation source delivers electrical current to the tissue via the electrode and the fluid.

28. The system of claim 18, wherein the ablation catheter includes an inflatable balloon mounted adjacent a distal end of the ablation catheter, an electrode disposed within the balloon, and a fluid delivery port to deliver fluid to inflate the balloon, the balloon being sufficiently porous to permit flow of the fluid outside of the balloon, the system further comprising a fluid source to deliver the fluid to the balloon, wherein the ablation source delivers electrical current to the tissue via the electrode and the fluid within and outside the balloon.

29. The system of claim 28, wherein the balloon is sized, upon inflation, to contact a circumferential surface of the mucosal lining on multiple sides of the balloon.

30. The system of claim 28, wherein the balloon is sized, upon inflation, to contact a circumferential surface of a pylorus region of the stomach on multiple sides of the balloon.

31. A method for treating obesity, the method comprising ablating tissue within a stomach of a patient to alter gastric myoelectric activity.

32. The method of claim 31, wherein ablating tissue includes ablating at least a portion of a fundus layer of the stomach.

33. The method of claim 31, wherein ablating tissue includes ablating at least a portion of myenteric and submucosal layers of the stomach.

34. The method of claim 31, wherein ablating tissue includes:

introducing an ablation catheter to the stomach via an esophagus of the patient;

moving a distal end of the ablation catheter to a position proximal a mucosal lining of the stomach; and

activating an ablation probe carried by the ablation catheter to ablate at least a portion of a fundus layer of the stomach.

35. The method of claim 31, wherein the ablation probe includes an array of electrodes suspended at a distal end of the ablation catheter, the method further comprising moving the electrodes into contact with the mucosal lining, wherein activating the ablation probe includes delivering electrical current to a fundus layer of the stomach via the electrodes.

36. The method of claim 31, wherein the ablation probe includes a conductive coil extending from the distal end of the ablation catheter, the method further comprising moving the conductive coil into contact with the mucosal lining, wherein activating the ablation probe includes delivering electrical current to a fundus layer of the stomach via the conductive coil.

37. The method of claim 31, wherein the ablation probe includes a fluid delivery port at the distal end of the ablation catheter, and an electrode disposed adjacent the fluid delivery port, the method further comprising delivering fluid to the mucosal lining via the fluid delivery port, wherein activating the ablation probe includes delivering electrical current to a fundus layer of the stomach via the electrode and the fluid.

38. The method of claim 31, wherein the ablation probe includes an optical waveguide extending from the distal end of the ablation catheter, the method further comprising moving the optical waveguide into proximity with the mucosal lining, wherein activating the ablation probe includes delivering laser energy to a fundus layer of the stomach via the optical waveguide.

39. The method of claim 31, wherein the ablation catheter defines a cavity, one or more vacuum ports within the cavity, and the ablation probe is movable into the cavity, the method further comprising applying vacuum pressure to the vacuum ports to capture a portion of the a fundus layer of the stomach within the cavity, and moving the ablation probe into the captured fundus layer.

40. The method of claim 39, wherein the cavity defines a curvature to better conform to a curvature of the stomach.

41. The method of claim 39, wherein activating the ablation probe includes delivering electrical current to the captured a fundus layer via the ablation probe.

42. The method of claim 39, wherein activating the ablation probe includes delivering laser energy to the captured a fundus layer via the ablation probe.

43. The method of claim 39, wherein the ablation probe defines a conductive needle with a fluid delivery port, the method further comprising delivering fluid to the fundus layer via the fluid delivery port, wherein activating the ablation probe includes delivering electrical current to the fundus layer via the electrode and the fluid.

44. The method of claim 31, wherein the ablation catheter includes an inflatable balloon mounted adjacent a distal end of the ablation catheter, an electrode disposed within the balloon, and a fluid delivery port to deliver fluid to inflate the balloon, the balloon being sufficiently porous to permit flow of the fluid outside of the balloon, the method further comprising inflating the balloon, and placing the balloon in contact with the mucosal lining, wherein activating the ablation probe includes delivering electrical current to a fundus layer of the stomach via the electrode and the fluid within and outside the balloon.

45. An ablation system comprising:

a catheter sized for introduction into a stomach of a patient;

an ablation probe disposed at a distal end of the catheter; and

an ablation source to control delivery of ablation energy via the ablation probe in an amount sufficient to ablate tissue within the stomach of the patient and alter gastric myoelectric activity.

46. The system of claim 45, wherein the catheter has a length sufficient to extend into the stomach of the patient via an esophagus of the patient.

47. The system of claim 45, wherein the ablation probe includes an array of electrodes suspended at the distal end of the ablation catheter, the ablation source delivering electrical current to the electrodes.

48. The system of claim 45, wherein the ablation probe includes a conductive coil extending from the distal end of the ablation catheter, the ablation source delivering electrical current to the tissue via the electrodes.

49. The system of claim 45, wherein the ablation probe includes a fluid delivery port at the distal end of the ablation catheter, and an electrode disposed adjacent the fluid delivery port, the system further comprising a fluid source to deliver fluid via the fluid delivery port, wherein the ablation source delivers electrical current to the tissue via the electrode and the fluid.

50. The system of claim 45, wherein the ablation probe includes an optical waveguide extending from the distal end of the ablation catheter, wherein the ablation source delivers laser energy to the tissue via the optical waveguide.

51. The system of claim 45, wherein the ablation catheter defines a cavity, one or more vacuum ports within the cavity, and the ablation probe is movable into the cavity, the system further comprising a vacuum source to apply vacuum pressure to the vacuum ports to capture a portion of fundus tissue within the cavity, wherein the ablation probe ablates at least a portion of the captured fundus tissue.

52. The method of claim 51, wherein the cavity defines a curvature to better conform to a curvature of the stomach.

53. The system of claim 51, wherein the ablation probe defines a conductive needle with a fluid delivery port, the system further comprising a fluid source to deliver fluid to the captured fundus tissue via the fluid delivery port, wherein the ablation source delivers electrical current to the fundus tissue via the electrode and the fluid.

54. The system of claim 45, wherein the ablation catheter includes an inflatable balloon mounted adjacent a distal end of the ablation catheter, an electrode disposed within the balloon, and a fluid delivery port to deliver fluid to inflate the balloon, the balloon being sufficiently porous to permit flow of the fluid outside of the balloon, the system further comprising a fluid source to deliver the fluid to the balloon, wherein the ablation source delivers electrical current to the tissue via the electrode and the fluid within and outside the balloon.